MR imaging of Crohn disease: use of perflubron as a gastrointestinal contrast agent
This study was undertaken to evaluate the use of perflubron (perfluorooctylbromide) as an oral contrast agent for magnetic resonance (MR) imaging of patients with Crohn disease. MR examinations were performed before and after perflubron administration in 12 patients with documented Crohn disease. Gl...
Saved in:
Published in | Journal of magnetic resonance imaging Vol. 4; no. 3; p. 491 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.1994
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!